Celldex Therapeutics, Inc.

Historical 13F Holders

Symbol
CLDX
CUSIP
15117B202
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 15117B202 since 12/18/2024, largest first.

Filer % of Class Filed
Wellington Management Group LLP 13G/A
12.2% 2/10/2026
Event 12/31/2025
FMR LLC 13G/A
10.7% 10/7/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 7.3% 4/17/2025
Event 3/31/2025
Kynam Capital Management, LP 13G/A
6.8% 8/14/2026
Event 6/30/2026
Price T Rowe Associates Inc /MD/ 13G 6.0% 8/14/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.2% 4/29/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Commodore Capital LP 13G/A
4.6% 11/14/2025
Event 9/30/2025
State Street Corp 13G 4.2% 5/12/2026
Event 3/31/2026
Point72 Asset Management, L.P. 13G/A
2.6% 3/10/2026
Event 12/31/2025
Eventide Asset Management, LLC 13G/A
2.0% 8/14/2025
Event 6/30/2025
Bellevue Group AG 13G/A
1.5% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 7 233 k $7.50 M
2026 Q2 273 88.7 M $3.27 B
2026 Q1 240 73.2 M $2.32 B
2025 Q4 195 73.6 M $2.00 B
2025 Q3 198 70.9 M $1.83 B
2025 Q2 194 73.4 M $1.49 B
2025 Q1 184 73.6 M $1.34 B
2024 Q4 195 73.7 M $1.86 B
2024 Q3 206 71.9 M $2.44 B
2024 Q2 197 70.0 M $2.59 B
2024 Q1 211 70.1 M $2.94 B
2023 Q4 187 62.3 M $2.47 B
2023 Q3 163 50.6 M $1.39 B
2023 Q2 165 50.2 M $1.70 B
2023 Q1 179 49.5 M $1.78 B
2022 Q4 191 51.0 M $2.27 B
2022 Q3 177 49.5 M $1.39 B
2022 Q2 193 48.3 M $1.30 B
2022 Q1 194 49.9 M $1.70 B
2021 Q4 206 46.8 M $1.81 B
2021 Q3 182 43.3 M $2.33 B
2021 Q2 148 36.6 M $1.23 B
2021 Q1 129 34.5 M $710 M
2020 Q4 145 37.4 M $656 M
2020 Q3 102 32.2 M $477 M
2020 Q2 89 27.8 M $361 M
2020 Q1 52 3.97 M $6.59 M
2019 Q4 54 4.01 M $8.94 M
2019 Q3 62 3.71 M $7.90 M
2019 Q2 64 3.47 M $9.29 M
2019 Q1 60 2.60 M $12.8 M
2018 Q4 1 100 k $20.0 k